CORTEXYME INC (CRTX) Stock Analyst Ratings
NASDAQ:CRTX - Nasdaq - US22053A1079 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 45% to CRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.7. This target is 1063.85% above the current price.
CRTX was analyzed by 11 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about CRTX.
In the previous month the buy percentage consensus was at a similar level.
CRTX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-05-11 | Credit Suisse | Maintains | Underperform |
| 2022-03-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-28 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-01-27 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2021-10-27 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2021-10-27 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-16 | Canaccord Genuity | Maintains | Buy |
| 2021-08-26 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-17 | Jefferies | Downgrade | Buy -> Hold |